Status:
COMPLETED
Laryngeal Mask Supreme™ Versus the I-gel™
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Patients Undergoing Elective General Anesthesia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
We evaluate two new developed airway devices, which provide patent airway during general anesthesia. In 60 patients undergoing elective general anesthesia, we will simulate a difficult airway by using...
Detailed Description
The LMA Supreme™ and the I-gel™ are both new developed supraglottic airway devices to provide patent airways during general anesthesia. So far, prospective randomized controlled trials comparing their...
Eligibility Criteria
Inclusion
- ASA 1-3 patients undergoing elective operation
Exclusion
- Not speaking german or refusing to participate
- BMI \>35, \<50kg
- Planned operation time \>4h
- High risk of aspiration
- Cervical spine disease, known difficult airway, mouth opening \<20mm
- Upper respiratory tract symptoms in the previous 10 days
- Preoperative sore throat
- Poor dentition with high risk of damage
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00653237
Start Date
March 1 2008
End Date
July 1 2008
Last Update
March 12 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Bern, Canton of Bern, Switzerland, CH-3010